BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Health Canada 

A.L. 0904A

Ottawa    K1A 0K9  Canada
Phone: 613-957-2991 Fax: 613-941-5366


SEARCH JOBS




Industry
Healthcare






 Company News
Aerie Pharmaceuticals, Inc. (AERI) Receives Health Canada "No Objection Letter" To Commence Phase 3 Registration Trial Of Rhopressatm In Patients With Glaucoma In Canada 7/24/2014 1:02:16 PM
Health Canada Approves Kane Biotech Inc. (KNE)'s DispersinB® For Human Use 7/23/2014 9:04:23 AM
BioMarin Pharmaceutical Inc. (BMRN) Announces Health Canada Approval Of VIMIZIMâ„¢ (elosulfase alfa) For The Treatment Of Morquio A Syndrome 7/7/2014 9:00:24 AM
Antibe Therapeutics Inc. Receives Approval From Health Canada To Begin Human Clinical Testing 6/19/2014 11:31:35 AM
Health Canada Approves Roche (RHHBY)'s HPV Test For First-Line Primary Screening Of Cervical Cancer And Roche Launches New Cytology Test To Provide The Most Comprehensive Portfolio For Cervical Cancer Screening 6/11/2014 9:19:58 AM
Hyperion Therapeutics Announces Health Canada Accepts RAVICTI® New Drug Submission With Priority Review 6/3/2014 9:16:56 AM
AbbVie (ABBV) Files New Drug Submission To Health Canada For Its Investigational, All-Oral, Interferon-Free Therapy For The Treatment Of Hepatitis C 5/22/2014 9:31:26 AM
Antibe Therapeutics Inc. Announces Submission Of Clinical Trial Application To Health Canada For ATB-346 5/21/2014 9:48:39 AM
Helix Biopharma (CC:HBP) Submits L-DOS47 Clinical Trial Application With Health Canada 5/14/2014 9:51:51 AM
Health Canada Approves EGRIFTA™ (Tesamorelin For Injection) And Theratechnologies Inc. (TH.TO) Regains Canadian Commercialization Rights To EGRIFTA™ 4/30/2014 11:36:05 AM
12345678910...